Patents Assigned to New Atlas Biotechnologies LLC
  • Processes for the production of tryptamines
    Patent number: 11136293
    Abstract: Disclosed herein are prokaryotic and eukaryotic microbes, including E. coli and S. cerevisiae, genetically altered to biosynthesize tryptamine and tryptamine derivatives. The microbes of the disclosure may be engineered to contain plasmids and stable gene integrations containing sufficient genetic information for conversion of an anthranilate or an indole to a tryptamine. The fermentative production of substituted tryptamines in a whole-cell biocatalyst may be useful for cost effective production of these compounds for therapeutic use.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: October 5, 2021
    Assignee: New Atlas Biotechnologies LLC
    Inventor: Ryan Protzko